SARS-CoV-2 Spike S1 Proteins
(SARS-CoV-2 Spike S1)
attaches the virion to the cell membrane by interacting with host receptor, initiating the infection (By similarity). Binding to human ACE2 receptor and internalization of the virus into the endosomes of the host cell induces conformational changes in the Spike glycoprotein (PubMed:32142651, PubMed:32075877, PubMed:32155444). Uses also human TMPRSS2 for priming in human lung cells which is an essential step for viral entry (PubMed:32142651). Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membranes fusion within endosomes.
Recommended next Filters:
Would you like to try our new AI Search?
104 results
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
WB
1 image
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: Escherichia coli (E. coli)
Recombinant
> 90 %
WB, SDS, Imm, PC
1 image
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
> 95 %
1 image
1 reference
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
SDS, ELISA
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
SDS, ELISA
Origin: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta
Host: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Origin: SARS Coronavirus-2 (SARS-CoV-2)
Host: HEK-293 Cells
Recombinant
>95 % (SDS-PAGE)
Active
Latest Publications for our SARS-CoV-2 Spike S1 Proteins
: "Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease." in: Brain, behavior, and immunity, Vol. 109, pp. 251-268, (2023) (PubMed).: "Point-of-care (POC) SARS-CoV-2 antigen detection using functionalized aerosol jet-printed organic electrochemical transistors (OECTs)." in: Nanoscale, Vol. 15, Issue 11, pp. 5476-5485, (2023) (PubMed).
: "Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection." in: Stroke, Vol. 52, Issue 1, pp. 260-270, (2021) (PubMed).
: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." in: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction." in: Journal of the American Society for Mass Spectrometry, (2021) (PubMed).
: "Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum." in: ACS infectious diseases, (2021) (PubMed).
: "Delayed production of neutralizing antibodies correlates with fatal COVID-19. ..." in: Nature medicine, (2021) (PubMed).
: "Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. ..." in: Cell reports. Medicine, pp. 100288, (2021) (PubMed).
: "A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes. ..." in: Nature communications, Vol. 12, Issue 1, pp. 2623, (2021) (PubMed).
Aliases for SARS-CoV-2 Spike S1 Proteins
Surface Glycoprotein (S) ProteinsE2 Proteins
Did you look for something else?
- SARS-CoV-2 Spike Proteins
- SARS-CoV-2 Nucleocapsid Proteins
- SARS-CoV-2 NSP7 Proteins
- SARS-CoV-2 NSP5 (3CL-Pro) Proteins
- SARS-CoV-2 NSP3 Proteins
- SARS-CoV Spike Proteins
- SARS-Coronavirus Nucleocapsid Protein Proteins
- SARS-Coronavirus Membrane Protein Proteins
- SARNP Proteins
- SARM1 Proteins
- SARDH Proteins
- Sarcolemma Associated Protein Proteins
- Sarcalumenin Proteins
- SAR1B Proteins
- SAR1A Proteins
- SAPS2 Proteins
- SAPS1 Proteins
- SAP30BP Proteins
- SAP30-Like Proteins
- SAP30 Proteins
- SARS-CoV-2 Spike S2 Proteins
- SARS2 Proteins
- SART1 Proteins
- SART3 Proteins
- SASH1 Proteins
- SASH3 Proteins
- SAT1 Proteins
- SAT2 Proteins
- SATB1 Proteins
- SATB2 Proteins
- SAV1 Proteins
- SBDS Proteins
- SBEM Proteins
- SBK1 Proteins
- SBNO1 Proteins
- SC4MOL Proteins
- SC5DL Proteins
- SCAMP1 Proteins
- SCAMP3 Proteins
- SCAND1 Proteins
You are here:
